CRP and neoplasm: Many inflammation related biomarkers have been evaluated as prognostic indicators in multiple malignancies, such as platelet to lymphocyte ratio (PLR)10, c-reactive protein (CRP)11, tumor associated macrophages (TAMs)12 and so on.